Hoping to boost indications for its blockbuster cancer med Darzalex and create a new line of pipeline meds, Genmab has promoted its head of oncology Tahamtan Ahmadi, M.D., Ph.D., to run its research.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,